MarketInOut Stock Screener Log In | Sign Up

First Tracks Biotherapeutics Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/30/2026
First Tracks Biotherapeutics Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1,921.06 mln
Float30.64 mln
Earnings Date11/05/2026

1-Year Forecast

74.17
Transformational upside

Relative Strength

98 / 100
Top performer

Debt / Equity

0.03
Debt-free

ROE

-39.35
Deeply negative

ROA

-35.40
Deeply negative

Business Description

First Tracks Biotherapeutics is a clinical-stage company based in San Diego, California, working to develop treatments for autoimmune and inflammatory diseases. The company has three drug candidates in its pipeline, each designed to reduce harmful immune activity through distinct biological pathways. Founded in 2019 and formerly known as Biopharma Co. Inc., the company changed its name in February 2026.

Key Fundamentals

EPS-4.71
ROE-39.35
ROIC-1,109
ROA-35.40
EBITDA, mln-83.53
EV / EBITDA-17.55
EV / EBIT-17.48

Quote Details

Last 45.08
Change -0.15 (-0.33%)
Open 45.03
Volume 431,525
Turnover 19,453,148
Average Volume 1,176,453

Financial Ratios

Leverage Ratio1.08
Current Ratio14.28
Price / Book9.51
Price / Tangible Book9.51
Debt / Equity0.03

Financial Strength

1-Year Target Price74.17
Short Ratio6.01

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 2.34% 81 / 100   
1 Month 32.9% 98 / 100   
2 Months 7.26% 85 / 100   
6 Months 101% 98 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog